China is a key growth driver and enabler to the Alexion 2030 ambition. China’s rare disease market has expanded rapidly over the past five years, while its access and reimbursement framework continues to evolve. Further development of dedicated rare disease policies, funding mechanisms, and an integrated access ecosystem will be important to recognize innovation and support sustainable patient access.The Alexion China strategic Access Lead is expected to play a strategic role in unlocking for China new innovative access opportunities and solutions to enable sustained expansion of Alexion’s portfolio in the countryWith a strong understanding of both the China specific environment and the rare diseases market access eco systems across key countries, closely collaborating with local country market access & corporate affairs teams, GVAP leadership team and other relevant global/regional cross functional teams, he/she plays a pivotal role in stimulating, shaping & enabling implementation of new market access strategy and solutions that would facilitate the successful establishment in China of a rare diseases specific market access eco-system.Based in Barcelona, the GVAP China strategic Access lead will work in close collaboration with both the AZ China team leading the integrated multifunction rare diseases market access-advocacy strategy (market access, corporate affairs, HeOR, medical, commercial, etc....) , GVAP leadership team and the relevant global/regional cross functional teams ( Corporate Affairs, medical, HeOR…).With his/her in-depth knowledge of the the rare diseases market access eco systems across key countries, he/she provides strategic Market access support to the China Rare Diseases team through the following main activities:For China & provinces in scope, he/she provides hands on experience and strategic guidance in establishing and driving an actionable cross-function Market Access & Pricing policy framework to accompany and reinforce local access strategy development and implementation. This includes,



for example supporting development of access-pricing policy priority objectives and defining corresponding access strategy objectives and related priority workstreams.In close collaboration & alignment with AZ China team, he/she supports, explores, proposes strategic access initiatives to unlock China rare diseases and/or payer policy to open opportunities to the successful establishment in China of a rare diseases specific market access & pricing eco-system. This includes supporting development and/or participating to local stakeholder engagement events, developing relevant RD narrative and/or access strategy position papers for external engagement with payers, government officials and other key stakeholders to enable the successful establishment in China of a rare diseases specific market access & pricing eco-systemHe/she supports strategic access capability building at country level by sharing best practices, co-developing and proactively providing tailored operational support necessary for the China teams to effectively navigate the RD landscape.Experience

proven market access experience working in constructing & implementing access & pricing strategies with confirmed examples of success through cross functional work and collaborationUnderstanding of the access and policy environment for rare diseases and/or specialized medicines in ChinaPreferably China country market expertise/experienceExperience of cross-functional project development and managementPrior rare disease or specialized drugs therapy area expertise.Relevant drug development and/or commercialization experience within the pharmaceutical/medical industry.Capabilities & skills - This role requires





ability to work across functions and mobilize positive relationships to effectively collaborate internally with both AZ China teams and relevant integral cross functionsability and demonstrated experience to engage externally with payers and other access stakeholdersExcellent track-record of managing and/or working in cross-functional projects, being able to integrate cross functional input into a consistent integrated strategy platformIn country and/or above country market access expertise/experiencehighly autonomous and effective communicators with cultural sensitivity and engagement skills across the diversity of Asia markets in scopestrategic planning capabilities & Ability to deal with complexity (China, portfolio, diseases)Master Degree or higher education including strong scientific backgroundFluency in Mandarin Chinese and English is HIGHLY DESIRED15-Oct-202614-Oct-2026Alexion is proud to be an Equal Employment Opportunity and affirmative action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact [email protected]. Alexion participates in E-Verify.

#J-18808-Ljbffr

📌 China Strategic Market Access Lead (Madrid)
🏢 AstraZeneca
📍 Madrid